- Home
- TSHA vs EVN Comparison
TSHA vs EVN Comparison
Compare TSHA & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- EVN
- Stock Information
- Founded
- TSHA 2019
- EVN 1998
- Country
- TSHA United States
- EVN United States
- Employees
- TSHA N/A
- EVN N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- EVN Investment Bankers/Brokers/Service
- Sector
- TSHA Health Care
- EVN Finance
- Exchange
- TSHA Nasdaq
- EVN Nasdaq
- Market Cap
- TSHA 397.8M
- EVN 410.0M
- IPO Year
- TSHA 2020
- EVN N/A
- Fundamental
- Price
- TSHA $2.71
- EVN $10.25
- Analyst Decision
- TSHA Strong Buy
- EVN
- Analyst Count
- TSHA 7
- EVN 0
- Target Price
- TSHA $7.00
- EVN N/A
- AVG Volume (30 Days)
- TSHA 5.2M
- EVN 101.2K
- Earning Date
- TSHA 05-15-2025
- EVN 01-01-0001
- Dividend Yield
- TSHA N/A
- EVN 4.78%
- EPS Growth
- TSHA N/A
- EVN N/A
- EPS
- TSHA N/A
- EVN 0.34
- Revenue
- TSHA $7,224,000.00
- EVN N/A
- Revenue This Year
- TSHA N/A
- EVN N/A
- Revenue Next Year
- TSHA N/A
- EVN N/A
- P/E Ratio
- TSHA N/A
- EVN $29.94
- Revenue Growth
- TSHA N/A
- EVN N/A
- 52 Week Low
- TSHA $1.05
- EVN $8.64
- 52 Week High
- TSHA $4.32
- EVN $10.45
- Technical
- Relative Strength Index (RSI)
- TSHA 60.38
- EVN 50.28
- Support Level
- TSHA $2.44
- EVN $10.21
- Resistance Level
- TSHA $2.95
- EVN $10.35
- Average True Range (ATR)
- TSHA 0.25
- EVN 0.11
- MACD
- TSHA -0.02
- EVN -0.01
- Stochastic Oscillator
- TSHA 51.60
- EVN 50.00
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.